2023
DOI: 10.1016/j.phro.2023.100425
|View full text |Cite
|
Sign up to set email alerts
|

Synthetic computed tomography generation for abdominal adaptive radiotherapy using low-field magnetic resonance imaging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 26 publications
0
2
0
Order By: Relevance
“…The pelvis and the head and neck can be treated using photon radiotherapy (RT) and proton therapy, which achieve high image similarity and dosimetry accuracy. As part of the feasibility phase of testing, application of DL algorithms to abdominal and thoracic positions with significant motion are showing promise ( 37 , 41 , 59 , 60 , 86 , 89 , 104 , 116 118 , 185 , 231 ). The MR-only simulation of pediatric patients could be extremely beneficial when their simulations are repeated since they are more radiation-sensitive than adults.…”
Section: Discussionmentioning
confidence: 99%
“…The pelvis and the head and neck can be treated using photon radiotherapy (RT) and proton therapy, which achieve high image similarity and dosimetry accuracy. As part of the feasibility phase of testing, application of DL algorithms to abdominal and thoracic positions with significant motion are showing promise ( 37 , 41 , 59 , 60 , 86 , 89 , 104 , 116 118 , 185 , 231 ). The MR-only simulation of pediatric patients could be extremely beneficial when their simulations are repeated since they are more radiation-sensitive than adults.…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, only two studies incorporated multi-view slices and none of them explored the use of low-field MR scans. The latter has only been investigated for abdomen, prostate, and lung cancer [39] , [40] , [41] , [42] , [43] , [44] , [45] , resulting in promising image similarity scores (MAE = 26–90 HU) and dose metric accuracies (DVH = 1–5%). However, and, like the HN cancer studies, none of these studies investigated the use of ViTs.…”
Section: Introductionmentioning
confidence: 99%